Programme for Intervention in Paediatric Obesity
Launched by MAIMÓNIDES BIOMEDICAL RESEARCH INSTITUTE OF CÓRDOBA · Jun 7, 2024
Trial Information
Current as of September 09, 2025
Recruiting
Keywords
ClinConnect Summary
The Programme for Intervention in Paediatric Obesity, also known as the PinPo program, is a clinical trial aimed at helping children aged 6 to 12 years who are struggling with obesity. This program is designed for children who have a body mass index (BMI) higher than the 99th percentile, meaning they are significantly heavier than most children their age. Over the course of the program, participants and their family members will attend nine educational sessions held every two weeks at a hospital. These sessions will last about 90 minutes each and will be led by a team of experts in pediatrics, psychology, nursing, and nutrition. The goal is to motivate children and their families to adopt healthier lifestyle habits.
To be eligible for this trial, children need to be between 6 and 12 years old and have a BMI above the 99th percentile. However, children younger than 6 or older than 12, as well as those with chronic diseases or who are on special diets, will not be able to participate. This program is currently recruiting participants, and it offers a supportive environment where children and their caregivers can learn together and work towards better health.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Children between 6 and 12 years old, with a BMI greater than the 99th percentile according to Cole criteria (2004).
- Exclusion Criteria:
- • Children \< 6, or \> 12 years.
- • Children with chronic diseases or following a therapeutic diet.
- • Children with intervention in other centers.
About Maimónides Biomedical Research Institute Of Córdoba
The Maimónides Biomedical Research Institute of Córdoba is a leading research organization dedicated to advancing biomedical science through innovative clinical trials and translational research. Located in Córdoba, Spain, the institute focuses on a multidisciplinary approach to address pressing health challenges, fostering collaboration among researchers, clinicians, and industry partners. Its commitment to excellence in research is complemented by state-of-the-art facilities and a robust ethical framework, ensuring the highest standards of scientific integrity and patient safety. By prioritizing cutting-edge research and the development of novel therapeutic strategies, the Maimónides Biomedical Research Institute aims to contribute significantly to the improvement of global health outcomes.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Córdoba, Spain
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported